Literature DB >> 1694161

Fetal hemoglobin in normal adults and beta-thalassemia heterozygotes.

A Kutlar1, F Kutlar, L G Gu, S M Mayson, T H Huisman.   

Abstract

A recently developed high performance liquid chromatographic (HPLC) procedure using a weak cation exchanger (PolyCAT) in columns of different sizes was used to quantify fetal hemoglobin (HbF) in blood of normal adults and beta-thalassemia (beta-thal) heterozygotes with ten different types of mutations. Preparative PolyCAT-HPLC greatly facilitated the characterization of isolated HbF, i.e., the determination of the relative quantities of the G gamma and A gamma chains. The method is accurate and allows quantitation of Hb F at the 0.5% level; preparative PolyCAT-HPLC allows isolation of (nearly) pure Hb F from blood samples with low (less than 1%) Hb F. Adult Hb F levels were determined in 69 normal adults (including 24 diabetics); Hb F levels fell below 1% except for subjects with abnormal -- G gamma -- G gamma -- arrangement and a C----T mutation at position -158 relative to the Cap site of both G gamma genes. The effect of the same mutation in the normal -- G gamma -- A gamma-arrangement was variable. Certain beta-thal mutations (namely, those at positions -29; -88; IVS-I-1; IVS-II-1) were associated with high Hb F levels in heterozygotes, while those at nucleotide (nt) positions IVS-I-6; IVS-I-110; codon 24; codon 39; codons 41/42; IVS-II-745 were not. G gamma values varied and often fell into two groups (high G gamma and low G gamma); high G gamma values were not associated with high Hb F values. The chromatographic procedure is ideally suited for Hb A2 quantitation. Average values of Hb A2 in beta-thal heterozygotes with any one of nine of the ten mutations were twice that of normals; the one exception was the beta-thal heterozygote with the IVS-I-6 (T----C) mutation with an average low Hb A2 value of 3.6%.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1694161     DOI: 10.1007/bf00276333

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  25 in total

1.  Studies on human foetal haemoglobin. III. The hereditary haemoglobinopathies and thalassaemias.

Authors:  G H BEAVEN; M J ELLIS; J C WHITE
Journal:  Br J Haematol       Date:  1961-04       Impact factor: 6.998

2.  Studies on human foetal haemoglobin. I. Detection and estimation.

Authors:  G H BEAVEN; M J ELLIS; J C WHITE
Journal:  Br J Haematol       Date:  1960-01       Impact factor: 6.998

3.  Estimation of small percentages of foetal haemoglobin.

Authors:  K BETKE; H R MARTI; I SCHLICHT
Journal:  Nature       Date:  1959-12-12       Impact factor: 49.962

4.  Variations in G gamma and A gamma ratios in the fetal hemoglobin of newborn babies.

Authors:  T H Huisman; Y J Fei; F Kutlar
Journal:  Hemoglobin       Date:  1988       Impact factor: 0.849

5.  A G to A nucleotide substitution 161 base pairs 5' of the G gamma globin gene cap site (-161) in a high G gamma non-anemic person.

Authors:  J G Gilman; F Kutlar; M E Johnson; T H Huisman
Journal:  Prog Clin Biol Res       Date:  1987

6.  High-performance liquid chromatographic separation of human haemoglobins. Simultaneous quantitation of foetal and glycated haemoglobins.

Authors:  E Bisse; H Wieland
Journal:  J Chromatogr       Date:  1988-12-29

Review 7.  The mutation and polymorphism of the human beta-globin gene and its surrounding DNA.

Authors:  S H Orkin; H H Kazazian
Journal:  Annu Rev Genet       Date:  1984       Impact factor: 16.830

8.  Studies of beta-thalassemia mutations in families living in three provinces in southern China.

Authors:  J Z Liu; Q S Gao; Z Jiang; C C Liang; K G Yang; G Y Wu; G F Long; Q Li; J Zhang; B Deng
Journal:  Hemoglobin       Date:  1989       Impact factor: 0.849

9.  Clinical and genetic heterogeneity in black patients with homozygous beta-thalassemia from the southeastern United States.

Authors:  J M Gonzalez-Redondo; T A Stoming; K D Lanclos; Y C Gu; A Kutlar; F Kutlar; T Nakatsuji; B Deng; I S Han; V C McKie
Journal:  Blood       Date:  1988-09       Impact factor: 22.113

View more
  12 in total

1.  The frequencies of Hbs S and C in Georgia and South Carolina.

Authors:  T H Huisman; H F Harris; A Stewart; A Kutlar; R J Gardner; C Green
Journal:  Hum Genet       Date:  1991-05       Impact factor: 4.132

2.  Compound heterozygosity for a beta zero-thalassemia (frameshift codons 38/39; -C) and a nondeletional Swiss type of HPFH (A----C at NT -110, G gamma) in a Czechoslovakian family.

Authors:  K Indrak; J Indrakova; F Kutlar; D Pospisilova; I Sulovska; E Baysal; T H Huisman
Journal:  Ann Hematol       Date:  1991-08       Impact factor: 3.673

3.  A Czechoslovakian teenager with Hb E-beta zero-thalassemia [IVS-I-1 (G----A)] complicated by the presence of an alpha-globin gene triplication.

Authors:  K Indrak; Y J Fei; H W Li; E Baysal; V Brabec; H Fortova; J Cermak; T H Huisman
Journal:  Ann Hematol       Date:  1991-07       Impact factor: 3.673

4.  Beta S haplotypes in various world populations.

Authors:  C Oner; A J Dimovski; N F Olivieri; G Schiliro; J F Codrington; S Fattoum; A D Adekile; R Oner; G T Yüregir; C Altay
Journal:  Hum Genet       Date:  1992-04       Impact factor: 4.132

Review 5.  Hb F in sickle cell anemia.

Authors:  A D Adekile; T H Huisman
Journal:  Experientia       Date:  1993-01-15

6.  The in vivo expression of the globin genes of the beta cistron in gamma-, delta-, and delta beta-thalassemia heterozygotes.

Authors:  A J Dimovski; A D Adekile; T H Huisman
Journal:  Experientia       Date:  1994-02-15

7.  Evaluation of high performance liquid chromatography for routine estimation of haemoglobins A2 and F.

Authors:  G B Tan; T C Aw; R A Dunstan; S H Lee
Journal:  J Clin Pathol       Date:  1993-09       Impact factor: 3.411

8.  Haplotypes in SS patients from Nigeria; characterization of one atypical beta S haplotype no. 19 (Benin) associated with elevated HB F and high G gamma levels.

Authors:  A D Adekile; M N Kitundu; L H Gu; K D Lanclos; O O Adeodu; T H Huisman
Journal:  Ann Hematol       Date:  1992-07       Impact factor: 3.673

9.  Molecular characterization of beta-thalassemia in Azerbaijan.

Authors:  M A Cürük; G T Yüregir; C D Asadov; T Dadasova; L H Gu; E Baysal; Y C Gu; M L Ribeiro; T H Huisman
Journal:  Hum Genet       Date:  1992-12       Impact factor: 4.132

10.  Sickle cell anemia, sickle cell beta-thalassemia, and thalassemia major in Albania: characterization of mutations.

Authors:  E Boletini; M Svobodova; V Divoky; E Baysal; M A Cürük; A J Dimovski; R Liang; A D Adekile; T H Huisman
Journal:  Hum Genet       Date:  1994-02       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.